Dr. Agarwal's Eye (DRAGARWQ) | Stock Overview & Key Data
Dr. Agarwal's Eye Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹7,300.00 on December 30, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dr. Agarwal's Eye
DRAGARWQ
|
24.28B Small-cap | 0.12% | -1.62% | 6.94% | -8.52% | -6.31% | 12.35% | 240.02% | 1,131.89% | 2,480.68% | 5,282.48% | 17,498.05% |
|
Apollo Hospitals
APOLLOHOSP
|
1.12T Large-cap | 1.38% | 4.79% | 13.08% | 19.52% | 19.10% | 21.50% | 63.42% | 163.79% | 556.24% | 1,658.87% | 4,106.51% |
|
Max Healthcare
MAXHEALTH
|
979.76B Large-cap | 2.13% | -2.02% | 6.01% | -5.21% | -1.95% | -17.87% | 70.33% | 304.25% | 806.00% | 806.00% | 806.00% |
|
Indraprastha Medical
INDRAMEDCO
|
37.31B Small-cap | -0.95% | 4.95% | -1.44% | -21.11% | -14.34% | -5.84% | 323.69% | 338.93% | 635.89% | 971.03% | 1,203.39% |
|
Shalby
SHALBY
|
16.70B Small-cap | -0.43% | 7.91% | 21.73% | -12.46% | -15.93% | -6.18% | 10.56% | 5.52% | -29.49% | -29.49% | -29.49% |
|
KMC Speciality
KMCSHIL
|
14.64B Small-cap | 5.86% | 25.78% | 46.86% | 57.94% | 48.70% | 75.08% | 79.95% | 209.93% | 1,499.87% | 6,792.44% | 34,767.65% |
Ownership & Short Interest
Calculate Your Dr. Agarwal's Eye Investment Returns
Long-Term Investment Performance Analysis
Dr. Agarwal's Eye stock price in Jul 2016 was ₹215.50, A ₹1,000.00 lump sum investment in Dr. Agarwal's Eye made 9 years ago would be worth approximately ₹23,161.02 today, representing a exceptional return of 2,216.10%. This translates to an annualized return (CAGR) of 37.32%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is DRAGARWQ's 52-week high and low?
- In the last 52 weeks, Dr. Agarwal's Eye reached a high of ₹6,392.00 (on January 2, 2026) and a low of ₹4,142.00 (on June 23, 2025).
- What is the market cap and P/E ratio for DRAGARWQ?
- Curious about Dr. Agarwal's Eye's size and valuation? Its market capitalization stands at 24.28B. When it comes to valuation, the P/E ratio (trailing twelve months) is 34.01, and the forward P/E (looking ahead) is 516.77.
- Does DRAGARWQ pay dividends? If so, what's the yield?
- Yes, Dr. Agarwal's Eye is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.11%, and the company has paid an average of ₹4.50 per share annually over the past 3 years.
- Who are Dr. Agarwal's Eye's main competitors or similar companies to consider before investing?
When looking at Dr. Agarwal's Eye, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Apollo Hospitals
APOLLOHOSP1.12T Healthcare Medical Care Facilities 21.50% 63.42% Max Healthcare
MAXHEALTH979.76B Healthcare Medical Care Facilities -17.87% 70.33% Indraprastha Medical
INDRAMEDCO37.31B Healthcare Medical Care Facilities -5.84% 323.69% Shalby
SHALBY16.70B Healthcare Medical Care Facilities -6.18% 10.56% KMC Speciality
KMCSHIL14.64B Healthcare Medical Care Facilities 75.08% 79.95% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Dr. Agarwal's Eye Hospital Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Dr. Agarwal's Eye's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 26.07%, the Debt to Equity ratio from the most recent quarter is 106.45, and its Gross Profit Margin stands at 78.09%.
- What is the recent revenue and earnings growth for DRAGARWQ?
- Looking at Dr. Agarwal's Eye's growth, its revenue over the trailing twelve months (TTM) was INR5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 22.20%, and quarterly earnings saw a YoY growth of 66.20%.
- How much of DRAGARWQ stock is held by insiders and institutions?
- Wondering who owns Dr. Agarwal's Eye stock? Company insiders (like executives and directors) hold about 77.59% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 3.57%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.